Evidence generation in Europe- How valuable is the French National administrative health data (SNDS) On-Demand Webinar Evidence generation in Europe- How valuable is the French National administrative health data (SNDS) Watch this presentation to learn • Overview of the SNDS and the key working practices…Certara2021 年 5 月 7 日
Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States Publication Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States Authors: Joseph McGuirk, Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang, Genovefa A. Papanicolaou…Certara2021 年 4 月 8 日
Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure On-Demand Webinar Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…Certara2021 年 4 月 1 日
Legislators: Bring all stakeholders to the table to lower drug costs Press Coverage Legislators: Bring all stakeholders to the table to lower drug costs BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…Certara2021 年 3 月 30 日
Strategic Evidence & Value Communication Symposium On-Demand Webinar 战略证据与价值传播研讨会 Join us on 2021 年 4 月 21 日, 星期三, from12:00 PM – 2:00 PM EDT for Certara’s…Certara2021 年 3 月 26 日
Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software Case Study 利用 Certara GlobalSubmit eCTD 软件,Prelude Therapeutics 将其质量控制 (QC) 流程从数小时缩短到了数分钟 In 2019, Prelude Therapeutics, a small cancer drug discovery company, implemented Certara’s GlobalSubmit submissions management…Certara2021 年 3 月 2 日
Early Value Assessment in Gene Therapy Clinical Trial Design Case Study 基因治疗临床试验设计中的早期价值评估 A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…Certara2021 年 2 月 12 日
Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines White Paper Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines Certara2021 年 2 月 3 日
Getting Real with RWE Press Coverage Getting Real with RWE By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…Certara2020 年 11 月 20 日
Galderma Achieves FDA Approval of AKLIEF® (trifarotene) Case Study Galderma AKLIEF®(曲法罗汀)获得了 FDA 批准 In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…Certara2020 年 11 月 9 日